Shire hit by bowel drug study failure

LONDON (Reuters) - Shire was hit on Friday by the failure of a clinical study that could have opened up an important new market for its bowel drug Lialda, sending shares in the specialty drugmaker 4...

Source: http://feeds.reuters.com/~r/reuters/globalmarketsNews/~3/kqfC3Oo_uQ4/us-shire-idUSBRE82T0JQ20120330

domestic news summit news sports news make money online money save money